Cargando…

Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania

BACKGROUND: Most breast cancer diagnoses in Tanzania are in advanced stages. The Ocean Road Cancer Institute (ORCI) established a new breast cancer screening program in 2014 to reduce advanced-stage diagnoses. This study is aimed at describing the screening program's referral process and at ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherlin, Darcy S., Mwaiselage, Julius, Msami, Khadija, Heisler, Zoe, Young, Heather, Cui, Xingwei, Soliman, Amr S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005288/
https://www.ncbi.nlm.nih.gov/pubmed/35425839
http://dx.doi.org/10.1155/2022/9795534
_version_ 1784686425949601792
author Cherlin, Darcy S.
Mwaiselage, Julius
Msami, Khadija
Heisler, Zoe
Young, Heather
Cui, Xingwei
Soliman, Amr S.
author_facet Cherlin, Darcy S.
Mwaiselage, Julius
Msami, Khadija
Heisler, Zoe
Young, Heather
Cui, Xingwei
Soliman, Amr S.
author_sort Cherlin, Darcy S.
collection PubMed
description BACKGROUND: Most breast cancer diagnoses in Tanzania are in advanced stages. The Ocean Road Cancer Institute (ORCI) established a new breast cancer screening program in 2014 to reduce advanced-stage diagnoses. This study is aimed at describing the screening program's referral process and at identifying patient and health system factors that contribute to patients completing diagnostic testing referrals. METHODS: Six-hundred and forty patients were included in the study. Testing types, outcomes, and date of diagnostic results were abstracted from records at ORCI and Muhimbili National Hospital (MNH) to determine the proportion of testing completed and the duration between initial referrals and diagnostic tests. Prediction of completion of diagnostic testing was investigated in logistic regression. RESULTS: Of the patients who received referrals for further testing, fifty-two percent completed the recommended ultrasound (USS), mammography (MMG), and fine-needle aspiration cytology (FNAC). Only 33.0% of patients completed the recommended MMG referrals compared to 55.0% for ultrasound and 68.7% for FNAC. The average number of days between initial screening and results was 42 days for MMG, 20 days for USS, and 18 days for FNAC. Significant predictors for completing referrals for USS, FNAC, and MMG included age < 44 and >55 years, presenting with symptoms at the initial appointment, and education. The odds of completing an USS was 3.03 (95% CI, 1.65-5.64) for patients 25–34, 2.27 (95% CI, 1.17-4.48) for patients 35–44, and 4.41 (95% CI, 1.66-10.11) for patients older than 55 years compared to the reference group (age 19–24). The presence of symptoms at the initial appointment was a significant predictor of FNAC. The odds of completing an FNAC was 1.55 (95% CI, 1.02-3.72) for symptomatic compared to nonsymptomatic patients. Education was a significant predictor of MMG. The odds of receiving MMG was 4.29 (95% CI, 1.05-21.00) for patients with tertiary education or higher compared to primary education or lower. Possession of health insurance for treatment and living in Dar es Salaam were not significant predictors. Discussion. Future research should focus on patients' understanding of recommended referrals and factors that influence decision-making. Investigating the cost effectiveness of scaling up screening programs and setting up a patient navigation program that follow patients as they complete the recommended treatment plan will be crucial for Tanzania and other developing countries as they seek to launch and strengthen screening programs.
format Online
Article
Text
id pubmed-9005288
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90052882022-04-13 Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania Cherlin, Darcy S. Mwaiselage, Julius Msami, Khadija Heisler, Zoe Young, Heather Cui, Xingwei Soliman, Amr S. Biomed Res Int Research Article BACKGROUND: Most breast cancer diagnoses in Tanzania are in advanced stages. The Ocean Road Cancer Institute (ORCI) established a new breast cancer screening program in 2014 to reduce advanced-stage diagnoses. This study is aimed at describing the screening program's referral process and at identifying patient and health system factors that contribute to patients completing diagnostic testing referrals. METHODS: Six-hundred and forty patients were included in the study. Testing types, outcomes, and date of diagnostic results were abstracted from records at ORCI and Muhimbili National Hospital (MNH) to determine the proportion of testing completed and the duration between initial referrals and diagnostic tests. Prediction of completion of diagnostic testing was investigated in logistic regression. RESULTS: Of the patients who received referrals for further testing, fifty-two percent completed the recommended ultrasound (USS), mammography (MMG), and fine-needle aspiration cytology (FNAC). Only 33.0% of patients completed the recommended MMG referrals compared to 55.0% for ultrasound and 68.7% for FNAC. The average number of days between initial screening and results was 42 days for MMG, 20 days for USS, and 18 days for FNAC. Significant predictors for completing referrals for USS, FNAC, and MMG included age < 44 and >55 years, presenting with symptoms at the initial appointment, and education. The odds of completing an USS was 3.03 (95% CI, 1.65-5.64) for patients 25–34, 2.27 (95% CI, 1.17-4.48) for patients 35–44, and 4.41 (95% CI, 1.66-10.11) for patients older than 55 years compared to the reference group (age 19–24). The presence of symptoms at the initial appointment was a significant predictor of FNAC. The odds of completing an FNAC was 1.55 (95% CI, 1.02-3.72) for symptomatic compared to nonsymptomatic patients. Education was a significant predictor of MMG. The odds of receiving MMG was 4.29 (95% CI, 1.05-21.00) for patients with tertiary education or higher compared to primary education or lower. Possession of health insurance for treatment and living in Dar es Salaam were not significant predictors. Discussion. Future research should focus on patients' understanding of recommended referrals and factors that influence decision-making. Investigating the cost effectiveness of scaling up screening programs and setting up a patient navigation program that follow patients as they complete the recommended treatment plan will be crucial for Tanzania and other developing countries as they seek to launch and strengthen screening programs. Hindawi 2022-04-05 /pmc/articles/PMC9005288/ /pubmed/35425839 http://dx.doi.org/10.1155/2022/9795534 Text en Copyright © 2022 Darcy S. Cherlin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cherlin, Darcy S.
Mwaiselage, Julius
Msami, Khadija
Heisler, Zoe
Young, Heather
Cui, Xingwei
Soliman, Amr S.
Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania
title Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania
title_full Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania
title_fullStr Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania
title_full_unstemmed Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania
title_short Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania
title_sort breast cancer screening in low-income countries: a new program for downstaging breast cancer in tanzania
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005288/
https://www.ncbi.nlm.nih.gov/pubmed/35425839
http://dx.doi.org/10.1155/2022/9795534
work_keys_str_mv AT cherlindarcys breastcancerscreeninginlowincomecountriesanewprogramfordownstagingbreastcancerintanzania
AT mwaiselagejulius breastcancerscreeninginlowincomecountriesanewprogramfordownstagingbreastcancerintanzania
AT msamikhadija breastcancerscreeninginlowincomecountriesanewprogramfordownstagingbreastcancerintanzania
AT heislerzoe breastcancerscreeninginlowincomecountriesanewprogramfordownstagingbreastcancerintanzania
AT youngheather breastcancerscreeninginlowincomecountriesanewprogramfordownstagingbreastcancerintanzania
AT cuixingwei breastcancerscreeninginlowincomecountriesanewprogramfordownstagingbreastcancerintanzania
AT solimanamrs breastcancerscreeninginlowincomecountriesanewprogramfordownstagingbreastcancerintanzania